Patents by Inventor Basil Hartzoulakis

Basil Hartzoulakis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Potassium Channel Blockers
    Publication number: 20100087437
    Abstract: The present invention provides a compound of formula (I) or its salts or pharmaceutically acceptable derivatives wherein R1, R2, R3, X1, and A are defined herein. The compounds are useful as potassium ion channel inhibitors.
    Type: Application
    Filed: August 31, 2009
    Publication date: April 8, 2010
    Applicant: Xention Limited
    Inventors: Derek Edward JOHN, Mushtag MULLA, Richard John HAMLYN, Simon Mark JONES, Derek Roland POLLARD, Basil HARTZOULAKIS, Helen PAYNE, David MADGE, John FORD
  • Arginine Derivatives with NP-I Antagonistic Activity
    Publication number: 20100022525
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Application
    Filed: October 4, 2007
    Publication date: January 28, 2010
    Inventors: Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman, Katie Ellard, Basil Hartzoulakis, Ashley Jarvis, Rosemary Lynch, Jamie Nally, David Selwood, Mark Stewart
  • GUANIDINE DERIVATIVES AS INHIBITORS OF DDAH
    Publication number: 20090069331
    Abstract: Compounds of formula (I) have been found to be useful as inhibitors of DDAH.
    Type: Application
    Filed: November 11, 2005
    Publication date: March 12, 2009
    Applicant: UCL Biomedica PLC c/o Finance Division University College of London
    Inventors: Patrick John Thompson Vallance, James Mitchell Leiper, David Lawrence Selwood, Sharon Rossiter, Basil Hartzoulakis